| 35th week of 2016 patent applcation highlights part 7 |
| Patent application number | Title | Published |
|---|
| 20160250123 | MEANS FOR DYEING HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS | 2016-09-01 |
| 20160250124 | AGENTS FOR OXIDATIVELY DYEING HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS | 2016-09-01 |
| 20160250125 | AGENT FOR THE OXIDATIVE DYEING OF HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS | 2016-09-01 |
| 20160250126 | MEANS FOR THE OXIDATIVE DYEING OF HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS | 2016-09-01 |
| 20160250127 | USE OF A POLYOL IN THE REMINERALISATION OF ENAMEL | 2016-09-01 |
| 20160250128 | TARGETED CAPSULES FOR THE DELIVERY OF SKIN WHITENING AGENTS IN THE SKIN | 2016-09-01 |
| 20160250129 | SOLUTION SOLUBILIZATION COMPOSITION OF INSOLUBLE MATERIAL AND METHOD FOR SOLUBILIZING INSOLUBLE MATERIAL USING SAME | 2016-09-01 |
| 20160250130 | Cosmetic formulation and device for the treatment of deep wrinkles of the skin by means of iontophoresis | 2016-09-01 |
| 20160250131 | Low-Stringiness Thickener and Cosmetic Material Admixed with Said Thickner | 2016-09-01 |
| 20160250132 | Method for Providing Visual Effects on Fibres | 2016-09-01 |
| 20160250133 | HAIR TREATMENT AGENT COMPRISING POLYALKOXY ALKYL AMINO-SUBSTITUTED SILOXANES | 2016-09-01 |
| 20160250134 | POLYMERS AND USES THEREOF | 2016-09-01 |
| 20160250135 | Styrene Maleic Anhydride Polymers in Cosmetics and Personal Care Products | 2016-09-01 |
| 20160250136 | UV CURABLE NAIL COATING COMPOSITIONS | 2016-09-01 |
| 20160250137 | PERSONAL CARE COMPOSITIONS CONTAINING FUNCTIONALIZED POLYMERS | 2016-09-01 |
| 20160250138 | HAIR TREATMENT COMPOSITIONS WITH SUBSTITUTED SILICONE(S) | 2016-09-01 |
| 20160250139 | HAIR TREATMENT AGENTS HAVING SUBSTITUTED SILICONE(S) | 2016-09-01 |
| 20160250140 | METHOD FOR STERILIZING PLANT SEED, PRESERVATION METHOD, COSMETIC SEED, AND COSMETIC SET COMPRISING COSMETIC SEED | 2016-09-01 |
| 20160250141 | USE OF A LYSATE OF A CULTURE OF A BACTERIUM OF THE VITREOSCILLA SP. GENUS FOR PREVENTING AND/OR TREATING HYPERSEBORRHOEIC CONDITIONS OF THE SCALP | 2016-09-01 |
| 20160250142 | INHALED AEROSOLIZED IMMUNO-CHEMOTHERAPY FOR THE TREATEMENT OF MDR TB | 2016-09-01 |
| 20160250143 | FOAM FORMATION DEVICE AND METHOD | 2016-09-01 |
| 20160250144 | DISINTEGRATING PARTICLE COMPOSITION PRODUCED BY TWO-STAGE WET GRANULATION PROCESS, AND INTRAORALLY DISINTEGRATING TABLET CONTAINING SAME COMPOSITION | 2016-09-01 |
| 20160250145 | Rapidly Dispersible Dosage Form of Oxcarbazepine | 2016-09-01 |
| 20160250146 | Hydrophobic Drug-Delivery Material, Method for Manufacturing Thereof and Methods for Delivery of a Drug-Delivery Composition | 2016-09-01 |
| 20160250147 | Solid Pharmaceutical Compositions Containing Pregabalin | 2016-09-01 |
| 20160250148 | TRIPULSE RELEASE STIMULANT FORMULATIONS | 2016-09-01 |
| 20160250149 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | 2016-09-01 |
| 20160250150 | CALCIUM CARBONATE GRANULATION | 2016-09-01 |
| 20160250151 | METHOD OF PREVENTION AND TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION | 2016-09-01 |
| 20160250152 | Nanogel-Mediated Drug Delivery | 2016-09-01 |
| 20160250153 | NOVEL METHODS | 2016-09-01 |
| 20160250154 | FILM DELIVERY SYSTEM FOR ACTIVE INGREDIENTS | 2016-09-01 |
| 20160250155 | FILMS AND DRUG DELIVERY SYSTEMS MADE THEREFROM | 2016-09-01 |
| 20160250156 | TRANSDERMAL PREPARATION | 2016-09-01 |
| 20160250157 | Tincture For Infusing Flavonoids And Methods Of Use | 2016-09-01 |
| 20160250158 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | 2016-09-01 |
| 20160250159 | COMPOSITION, USE THEREOF, AND METHODS OF MANUFACTURING | 2016-09-01 |
| 20160250160 | COMPOSITIONS FOR TREATING OR PREVENTING CARDIOVASCULAR DISEASE | 2016-09-01 |
| 20160250161 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | 2016-09-01 |
| 20160250162 | Epinephrine and Benadryl Delivery Method and Apparatus | 2016-09-01 |
| 20160250163 | COMPOUNDS SUITABLE FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS AS WELL AS METHODS FOR THE DIAGNOSIS/PROGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS | 2016-09-01 |
| 20160250164 | SYSTEMIC PRO-HEMOSTATIC EFFECT OF SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON ALFA-ADRENERGIC AND/OR BETA-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH | 2016-09-01 |
| 20160250165 | Method of Modulating the Activity of a Nucleic Acid Molecule | 2016-09-01 |
| 20160250166 | METHOD FOR TREATING CHIKUNGUNYA VIRUS INFECTION | 2016-09-01 |
| 20160250167 | Volatile Organic Compound Formulations Having Antimicrobial Activity | 2016-09-01 |
| 20160250168 | ESTERS OF SHORT CHAINS FATTY ACIDS FOR USE IN THE TREATMENT OF IMMUNOGENIC DISORDERS | 2016-09-01 |
| 20160250169 | COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION | 2016-09-01 |
| 20160250170 | MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF | 2016-09-01 |
| 20160250171 | USE OF TALL OIL FATTY ACID IN BINDING TOXINS | 2016-09-01 |
| 20160250172 | Neuroprotection in Demyelinating Diseases | 2016-09-01 |
| 20160250173 | COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS | 2016-09-01 |
| 20160250174 | MONOACYLGLYCEROLS FOR USE IN CONJUNCTION WITH A LIPASE INHIBITOR AND/OR DIETS LOW IN FAT AND/OR CALORIES | 2016-09-01 |
| 20160250175 | COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE | 2016-09-01 |
| 20160250176 | TREATMENT OF CATAPLEXY | 2016-09-01 |
| 20160250177 | MODIFIED DOCETAXEL LIPOSOME FORMULATIONS AND USES THEREOF | 2016-09-01 |
| 20160250178 | COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT | 2016-09-01 |
| 20160250179 | COMPOSITION FOR SUPPRESSING NEURAMINIDASE ACTIVITY COMPRISING GERANYLATED FLAVONOID DERIVED FROM PAULOWNIA TOMENTOSA AS ACTIVE INGREDIENT | 2016-09-01 |
| 20160250180 | ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY | 2016-09-01 |
| 20160250181 | Alternative ACT with Natural Botanical Active GRAS Ingredients for Treatment and Prevention of the ZIKA Virus | 2016-09-01 |
| 20160250182 | RAB7L1 INTERACTS WITH LRRK2 TO MODIFY INTRANEURONAL PROTEIN SORTING AND PARKINSON'S DISEASE RISK | 2016-09-01 |
| 20160250183 | PKC Delta Inhibitors for use as Therapeutics | 2016-09-01 |
| 20160250184 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | 2016-09-01 |
| 20160250185 | PHARMACEUTICAL COMPOSITION FOR CONTROLLING BODY MASS GAIN COMPRISING S-PHENOTROPIL | 2016-09-01 |
| 20160250186 | STABILIZED PHARMACEUTICAL DOSAGE FORMS COMPRISING ATRASENTAN | 2016-09-01 |
| 20160250187 | PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS | 2016-09-01 |
| 20160250188 | METHODS FOR TREATMENT OF MUSCULAR DYSTROPHIES | 2016-09-01 |
| 20160250189 | METHODS AND COMPOSITIONS FOR PRESERVING PHOTORECEPTOR AND RETINAL PIGMENT EPITHELIAL CELLS | 2016-09-01 |
| 20160250190 | N-METHYL PYRAZOLOANTHRONE FOR TREATMENT OF CANCER | 2016-09-01 |
| 20160250191 | SEPARASE INHIBITORS AND USES THEREOF | 2016-09-01 |
| 20160250192 | PRODUCTION METHOD OF PHARMACEUTICAL COMPOSITION CONTAINING CANDESARTAN CILEXETIL | 2016-09-01 |
| 20160250193 | POLYMORPHIC FORMS OF 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACE- TIC ACID AND USES THEREOF | 2016-09-01 |
| 20160250194 | Methods of Making and Using Thioxothiazolidine and Rhodanine Derivatives as HIV-1 and JSP-1 Inhibitors | 2016-09-01 |
| 20160250195 | TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS | 2016-09-01 |
| 20160250196 | SMALL MOLECULE SECURININE AND NORSECURININE ANALOGS AND THEIR USE IN INHIBITING MYELOPEROXIDASE | 2016-09-01 |
| 20160250197 | AN INHALABLE MEDICAMENT | 2016-09-01 |
| 20160250198 | Pirfenidone Treatment for Patients with Atypical Liver Function | 2016-09-01 |
| 20160250200 | SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES | 2016-09-01 |
| 20160250201 | DEVICE AND METHOD FOR DELIVERY OF A MEDICAMENT | 2016-09-01 |
| 20160250202 | Mast Cell Stabilizers to Prevent or Treat Laminitis | 2016-09-01 |
| 20160250203 | IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS | 2016-09-01 |
| 20160250204 | PROCESS FOR PREPARING OXYCODONE COMPOSITIONS | 2016-09-01 |
| 20160250205 | PROCESS FOR PREPARING OXYCODONE COMPOSITIONS | 2016-09-01 |
| 20160250206 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPITHELIAL WOUNDS | 2016-09-01 |
| 20160250207 | Treating Pain In Patients With Hepatic Impairment | 2016-09-01 |
| 20160250208 | TREATING ORGAN-SPECIFIC T CELL MEDIATED AUTOIMMUNE DISEASES | 2016-09-01 |
| 20160250209 | CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE | 2016-09-01 |
| 20160250210 | PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE | 2016-09-01 |
| 20160250211 | AURORA KINASE INHIBITORS | 2016-09-01 |
| 20160250212 | DNA-PK INHIBITORS | 2016-09-01 |
| 20160250213 | FORMULATIONS OF AZAINDOLE COMPOUNDS | 2016-09-01 |
| 20160250214 | METHOD FOR TREATING LIVER DISEASES OF VARIOUS ORIGINS | 2016-09-01 |
| 20160250215 | QUINAZOLINE COMPOUNDS | 2016-09-01 |
| 20160250216 | INHIBITION OF HIF-2ALPHA HETERODIMERIZATION WITH HIF1BETA (ARNT) | 2016-09-01 |
| 20160250217 | CRYSTALLINE FORM OF PEMIROLAST | 2016-09-01 |
| 20160250218 | PHARMACEUTICAL COMBINATION | 2016-09-01 |
| 20160250219 | SUBSTITUTED MORPHOLINES AS MODULATORS FOR THE CALCIUM SENSING RECEPTOR | 2016-09-01 |
| 20160250220 | TREATMENT FOR PANCREATIC CANCER | 2016-09-01 |
| 20160250221 | INHIBITORS OF FAPP2 AND USES THEREOF | 2016-09-01 |
| 20160250222 | DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE | 2016-09-01 |
| 20160250223 | 5HT2C RECEPTOR MODULATORS | 2016-09-01 |
